| Concord Biotech Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 543960 |
NSE Symbol : CONCORDBIO |
P/E(TTM) : 45.69 |
|
ISIN Demat : INE338H01029 |
Div & Yield% : 0.62 |
EPS(TTM) : 30.73 |
|
Book Value(₹) : 174.47 |
Market Cap(₹Cr) : 14,688.64 |
Face Value(₹) : 1.00 |
| Particulars | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| INCOME : | |||||
| Sales Turnover | - | - | - | - | - |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 1,200.09 | 1,016.94 | 853.17 | 712.93 | 616.94 |
| Other Income | 44.45 | 33.78 | 35.31 | 23.42 | 13.81 |
| Stock Adjustments | 14.79 | 12.08 | 15.63 | 23.98 | 39.05 |
| Total Income | 1,259.33 | 1,062.80 | 904.11 | 760.33 | 669.80 |
| EXPENDITURE : | |||||
| Raw Materials | 320.30 | 241.28 | 195.84 | 187.99 | 150.61 |
| Power and Fuel Cost | 112.23 | 104.97 | 97.65 | 71.64 | 39.86 |
| Other Manufacturing Expenses | 26.18 | 28.00 | 24.93 | 17.10 | 12.99 |
| Selling and Administration Expenses | 99.31 | 91.08 | 82.93 | 67.90 | 44.87 |
| Miscellaneous Expenses | 11.09 | 8.46 | 13.20 | 22.66 | 10.26 |
| Employee Benefit Expenses | 138.93 | 123.05 | 110.28 | 95.69 | 69.47 |
| Less: Preoperative Expenditure | - | - | - | - | - |
| Total Expenses | - | - | - | - | - |
| Operating Profit | 551.29 | 465.97 | 379.27 | 297.34 | 341.74 |
| Interest | 1.04 | 3.18 | 5.18 | 6.13 | 1.05 |
| Gross Profit | 550.25 | 462.79 | 374.09 | 291.21 | 340.69 |
| Depreciation | 54.37 | 53.59 | 54.03 | 50.05 | 27.52 |
| Profit Before Tax | 495.88 | 409.20 | 320.06 | 241.16 | 313.17 |
| Current Tax | 118.96 | 99.83 | 79.53 | 58.49 | 75.72 |
| Fringe Benefit tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 3.95 | 4.63 | 2.40 | 4.10 | 2.11 |
| Reported Net Profit | 372.96 | 304.73 | 238.13 | 178.57 | 235.33 |
| Extraordinary Items | 16.58 | 10.48 | 2.70 | 3.86 | 5.24 |
| Adjusted Net Profit | 356.38 | 294.25 | 235.43 | 174.71 | 230.09 |
| Adjustment below Net Profit | 5.97 | -0.01 | 0.26 | -0.56 | -0.04 |
| Profit/Loss Balance carried down | 1,403.60 | 1,170.33 | 985.51 | 878.02 | 648.43 |
| Statutory Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Appropriations | 91.54 | 71.45 | 53.56 | 70.52 | 5.71 |
| P & L Balance carried down | 1,691.00 | 1,403.60 | 1,170.33 | 985.51 | 878.02 |
| Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preference Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity Dividend (%) | 875.00 | 875.00 | 683.00 | 51.20 | 0.00 |
| Dividend Per Share(Rs) | 10.70 | 8.75 | 6.83 | 5.12 | 0.00 |
| Earnings Per Share-Unit Curr | 35.65 | 29.13 | 22.76 | 187.76 | 247.44 |
| Earnings Per Share(Adj)-Unit Curr | - | - | - | - | - |
| Book Value | 173.27 | 145.80 | 123.50 | 1,164.13 | 1,051.11 |
| Book Value(Adj)-Unit Curr | 173.27 | 145.80 | - | - | - |